Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-125129
Filing Date
2024-12-03
Accepted
2024-12-03 17:21:58
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2429853d3_defa14a.htm DEFA14A 180879
2 GRAPHIC tm2429853d3_defa14aimg001.jpg GRAPHIC 22040
3 GRAPHIC tm2429853d3_defa14aimg002.jpg GRAPHIC 9722
4 GRAPHIC tm2429853d3_defa14aimg003.jpg GRAPHIC 14024
5 GRAPHIC tm2429853d3_defa14aimg01.jpg GRAPHIC 2403
  Complete submission text file 0001104659-24-125129.txt   249143
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 241523771
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)